Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons

Author(s): Fulvio Lauretani, Gian Paolo Ceda, Pio Pelliccioni, Livia Ruffini, Anna Nardelli, Antonio Cherubini, Marcello Maggio.

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 19 , 2014

Submit Manuscript
Submit Proposal

Abstract:

The rapidly increasing elderly population poses a major challenge for future health-care systems. Neurological diseases in older persons are particularly common and coexist with other clinical conditions.

This is not surprising given that, for example, even patients with Alzheimer Disease (AD) could have relevant extrapyramidal signs at the moment of the diagnosis with motor signs having more negative prognostic value. Longitudinal studies conducted on Parkinson Disease (PD) showed that, after 20 years, dementia is not only present in almost all survivors but is also the main factor influencing nursing home admission.

Recently, it has been reported the importance of Comprehensive Geriatric Assessment (CGA: comprehensive evaluation of cognition, depressive symptoms, mobility and functional assessment) as a tool reducing morbidity in frail older patients admitted to any acute hospital unit. The CGA should be considered as a technological device, for physicians who take care of older persons affected by overlapping neurological diseases. CGA is an extraordinary and cost effective instrument even in patients with advanced neurological diseases where allows to collect valuable information for an effective plan of management.

Keywords: Neurological disease, older persons, mobility limitations, parkinsonism.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 20
ISSUE: 19
Year: 2014
Page: [3149 - 3164]
Pages: 16
DOI: 10.2174/13816128113196660687
Price: $58

Article Metrics

PDF: 18